BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6127382)

  • 1. Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen.
    Nunn B; Chamberlain PD
    J Pharm Pharmacol; 1982 Sep; 34(9):576-9. PubMed ID: 6127382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the inhibitory effect on platelet aggregation of various anti-inflammatory drugs].
    Migne J; Santonja R; Kunz S
    Therapie; 1973; 28(5):861-76. PubMed ID: 4368089
    [No Abstract]   [Full Text] [Related]  

  • 6. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL; Comai K; Kuhn DC; Paulsrud J
    Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
    [No Abstract]   [Full Text] [Related]  

  • 7. Arginine vasopressin release from human platelets after irreversible aggregation.
    Anfossi G; Mularoni E; Trovati M; Massucco P; Mattiello L; Emanuelli G
    Clin Sci (Lond); 1990 Jan; 78(1):113-6. PubMed ID: 2153488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid-induced human platelet aggregation and prostaglandin formation.
    Silver MJ; Smith JB; Ingerman C; Kocsis JJ
    Prostaglandins; 1973 Dec; 4(6):863-75. PubMed ID: 4205973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of heparin on platelet aggregation in vitro].
    RĂ³ka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis.
    Knijff-Dutmer EA; Martens A; vd Laar MA
    Ann Rheum Dis; 1999 Apr; 58(4):257-9. PubMed ID: 10364907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil: a potent inhibitor of platelet adhesiveness.
    Li XL; Steiner M
    Blood; 1990 Sep; 76(5):938-45. PubMed ID: 2118400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary arachidonate deficiency on the aggregation of cat platelets.
    MacDonald ML; Rogers QR; Morris JG
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 78(1):123-6. PubMed ID: 6146457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
    Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
    Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxygenase inhibitors alter aggregation and adhesiveness of human blood platelets from aspirin-treated patients.
    Gimeno MF; Shattner MA; Borda E; Gimeno AL; Lazzari MA
    Prostaglandins Leukot Med; 1983 May; 11(1):109-19. PubMed ID: 6410411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
    Yanagisawa H; Wada O
    Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.